Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Historical Holders from Q2 2018 to Q4 2024

Symbol
KZR on Nasdaq
CUSIP
49372L100
Type / Class
Equity / COMMON-STOCK
Shares outstanding
7.23M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
3.69K
Holdings value
$2.84K
% of all portfolios
0%
Grand Portfolio weight change
0%
Number of holders
1
Number of sells
-54
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Equal Talent Investments Ltd 8.66% $475K 617K Equal Talent Investments Limited Feb 28, 2025
Avidity Partners Management LP 6.9% $387K 503K Avidity Partners Management LP Dec 31, 2024
BML Investment Partners, L.P. 5.1% $284K 369K BML Investment Partners, L.P. Feb 28, 2025

Institutional Holders of Kezar Life Sciences Inc - COMMON-STOCK (KZR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 3.69K $2.84K -$28.9M $0.77 1
2024 Q3 37.4M $28.9M +$901K $0.77 54
2024 Q2 39.4M $23.6M -$4M $0.60 76
2024 Q1 44.7M $40.3M -$4.24M $0.90 80
2023 Q4 49.4M $46.8M -$6.13M $0.95 81
2023 Q3 55.5M $66M -$2.95M $1.19 81
2023 Q2 56.8M $139M -$10.7M $2.45 101
2023 Q1 60.1M $188M -$2.11M $3.13 134
2022 Q4 57.3M $403M -$11.1M $7.04 120
2022 Q3 56.5M $486M +$23.6M $8.61 126
2022 Q2 53.6M $443M +$61.1M $8.27 120
2022 Q1 44.1M $732M +$63.1M $16.62 119
2021 Q4 40M $668M +$203M $16.72 101
2021 Q3 28.1M $243M +$11M $8.64 75
2021 Q2 27.6M $150M +$4.15M $5.43 73
2021 Q1 26.6M $158M +$18.3M $5.96 81
2020 Q4 23.5M $123M +$2.01M $5.22 75
2020 Q3 23.2M $112M -$610K $4.84 75
2020 Q2 23.2M $120M +$22.7M $5.18 82
2020 Q1 18.5M $80.6M +$40.7M $4.36 58
2019 Q4 9.17M $36.8M -$693K $4.01 54
2019 Q3 9.42M $30.9M -$5.4M $3.28 53
2019 Q2 10M $77.1M +$6.87M $7.71 52
2019 Q1 9.92M $176M +$12.2M $17.74 50
2018 Q4 9.33M $220M +$13.7M $23.60 39
2018 Q3 8.8M $188M +$21.7M $21.41 35
2018 Q2 7.91M $135M +$105M $17.30 26